Tonix Pharmaceuticals
TNXP
#10221
Rank
NZ$99.8 M
Marketcap
NZ$5.14
Share price
-4.08%
Change (1 day)
-82.18%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -NZ$0.29 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are NZ$29.1 Million. In 2025 the company made an earning of -NZ$0.23 Billion a decrease over its 2024 earnings that were of -NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.29 Billion27.76%
2025 -NZ$0.23 Billion61.37%
2024 -NZ$0.14 Billion-36.5%
2023 -NZ$0.22 Billion5.61%
2022 -NZ$0.21 Billion21.43%
2021 -NZ$0.17 Billion82.76%
2020 -NZ$92 Million75.22%
2019 -NZ$52.51 Million9.52%
2018 -NZ$47.95 Million23.63%
2017 -NZ$38.78 Million-45.36%
2016 -NZ$70.98 Million-19.09%
2015 -NZ$87.72 Million74.15%
2014 -NZ$50.37 Million153.99%
2013 -NZ$19.84 Million
2011 -NZ$9.57 Million29538.74%
2010 -NZ$0.04 Million-42.58%
2009 -NZ$0.06 Million46.05%
2008 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-NZ$42.33 Million-85.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$64.94 M-121.96%๐Ÿ‡บ๐Ÿ‡ธ USA